Global Declotting Devices Market, By Product (Mechanical Declotting Device, Embolectomy Balloon), End Use (Hospitals, Clinics, Others) – Industry Trends and Forecast to 2029.
Declotting Devices Market Analysis and Size
Dialysis interventions for fistula/graft declotting increase blood flow in these artificial blood vessel connections, which aid renal dialysis, a procedure that uses a specific machine to remove waste from the body. These connections may become obstructed or constrictive, necessitating angioplasty, vascular stenting, or catheter-directed thrombolysis.
Data Bridge Market Research analyses that the declotting devices market which will be 2.40 billion by 2029 during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Declotting Devices Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Mechanical Declotting Device, Embolectomy Balloon), End Use (Hospitals, Clinics, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Fresenius Medical Care AG & Co. KGaA (Germany), Baxter (U.S.), Rockwell Medical, Inc. (U.S.), Medivators, Inc. (U.S.), B. Braun Melsungen AG (Germany), Nipro Medical Corporation (Japan), Asahi Kasei Medical Co. Ltd. (Japan), Medical Components Inc. (U.S.), Medtronic (Ireland) and Teleflex Incorporated (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Declotting is to remove blood clots from the serum histidine concentration in casual samples, properly declotted and stored. Fistula declotting, also known as fistula declotting, is a frequent interventional treatment used in grafts and arteriovenous fistulae. Declots are performed on arteriovenous fistulas and grafts to clear any obstructions or constrictions and increase blood flow.
Global Declotting Devices Market Dynamics
Drivers
- Technological developments
The development of revolutionary next-generation thrombectomy tools and the rapid improvement of technological advancement will boost the market launch of declotting devices. Rapid administrative approvals for self-monitoring systems will increase the market share for declotting devices. The growing older population, which is more prone to contracting such infections, is a factor in the expansion.
- Increasing demand for minimally invasive procedures
According to the World Health Organization (WHO), worldwide, 17.9 million people die from cardiovascular disorders each year. Additionally, the market is anticipated to rise due to the rising occurrence of heart attacks and strokes, which are the main factors driving the demand for minimally invasive treatments for blood clots.
Opportunities
- Rising demand of declotting devices
The market for declotting devices is anticipated to grow as more patients experience hip, knee, and spinal operations, which are stroke risk factors. In addition, obesity and other vein-related disorders brought by sedentary lifestyles and improper eating habits are anticipated to spur market expansion throughout the forecast period.
Restraints/Challenges
- High cost of declotting devices
High cost coupled with declotting devices will hinder the growth of the declotting devices will obstruct the market's growth rate.
This declotting devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the declotting devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In 2019, Diligent Robotics launched its first "Moxi" AI-powered medical assistant, which provides personal protective equipment (PPE) kits, COVID-19 tests, and other lab samples in the hospitals where it is stationed. This lowers infection rates and saves lives.
- In January 2021, Johnson & Johnson Medical Devices Company, a top producer of medical equipment, received FDA approval for "VELYS". In an effort to create a connected digital surgery platform, the business created the robotically assisted medical equipment VELYS specifically for the Attune total knee system.
Global Declotting Devices Market Scope
The declotting devices market is segmented on the basis of product and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Mechanical Declotting Device
- Embolectomy Balloon
End Use
- Hospitals
- Clinics
- Others
Declotting Devices Market Regional Analysis/Insights
The declotting devices market is analysed and market size insights and trends are provided by country, product and end use as referenced above.
The countries covered in the declotting devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the declotting devices market due to the share large market share of U.S. in the availability of declotting devices.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to the growing inventive and interdisciplinary technologies and products in this particular region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Declotting Devices Market Share Analysis
The declotting devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to declotting devices market.
Some of the major players operating in the declotting devices market are:
- Fresenius Medical Care AG & Co. KGaA (Germany)
- Baxter (U.S.)
- Rockwell Medical, Inc. (U.S.)
- Medivators, Inc. (U.S.)
- B. Braun Melsungen AG (Germany)
- Nipro Medical Corporation (Japan)
- Asahi Kasei Medical Co. Ltd. (Japan)
- Medical Components Inc. (U.S.)
- Medtronic (Ireland)
- Teleflex Incorporated (U.S.)
SKU-
